RedHill Biopharma Ltd.
RDHLNasdaqHealthcare · Pharmaceutical Preparations · L3 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Ya Ii Pn, Ltd.Passive (13G)Dec 23, 2025
- Alumni Capital LpPassive (13G)Oct 20, 2025
- Quintairos, Prieto, Wood & Boyer P.A.Activist (13D)Aug 7, 2024
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Raday GileadOfficer — Chief Operating Officer | Apr 6, 2026 | Sell | 15.7M | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 21,811 | 1.0 | +14.4% |
| Apr 30, 2026 | 19,071 | 1.0 | +166.2% |
| Apr 15, 2026 | 7,163 | 1.0 | -63.5% |
| Mar 31, 2026 | 19,603 | 1.0 | +1.9% |
| Mar 13, 2026 | 19,232 | 1.0 | -32.8% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.